Evaluation of Cardiac ß-Adrenoreceptors in the Isolated Perfused Rat Heart Using (S)-11C-CGP12388
Mitsuru Momose, MD1,
Sybille Reder, MT1,
David M. Raffel, PhD2,
Petra Watzlowik, PhD1,
Hans-Jürgen Wester, PhD1,
Ngoc Nguyen, MT1,
Philip H. Elsinga, PhD3,
Frank M. Bengel, MD1,
Joerg Remien, MD4 and
Markus Schwaiger, MD1
1 Nuklearmedizinische Klinik und Poliklinik der Technischen Universität München, Munich, Germany
2 Department of Radiology, University of Michigan, Ann Arbor, Michigan
3 PET Center, Groningen University Hospital, Groningen, The Netherlands
4 Walther Straub für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany

View larger version (21K):
[in a new window]
|
FIGURE 1. Compartmental model describing the kinetics of a receptor-binding radioligand administered as a bolus injection into the perfused rat heart.
|
|

View larger version (14K):
[in a new window]
|
FIGURE 2. In vitro binding of 3H-CGP12177 to ß-adrenoreceptors in membrane preparations: representative saturation binding assay curve for a heart from the group perfused at 6 mL/min (A), Scatchard plot using data from the same heart (B), and saturation binding assay curve for a heart from the propranolol-blocking group (C). No specific binding can be detected in this study.
|
|

View larger version (18K):
[in a new window]
|
FIGURE 3. Representative timeactivity curves for each group: high-flow study (A), low-flow study (B), and ß-blocker study (C). In each group, a second injection with lower specific activity was performed 25 min after the first injection. inj = injection.
|
|

View larger version (19K):
[in a new window]
|
FIGURE 4. (A) Relationship between Bmax measured in the isolated perfused heart and in vitro. (B) Relationship between KD measured in isolated hearts and in vitro.
|
|
Copyright © 2004 by the Society of Nuclear Medicine.